Lrrk2 flox-R1441G

Output Details

Dardarin, also known as leucine-rich repeat kinase 2 (coded by *Lrrk2*), is involved in regulating inflammation, protein processing, and autophagy. *Lrrk2* mutations have been implicated in familial Parkinson's disease. The R1441G clinical mutation occurs in the 'Ras of complex proteins' (ROC) domain of the leucine-rich repeat kinase 2 protein, reducing GTPase activity. These LRRK2 flox-R1441G mice possess *loxP* sites flanking wildtype exons 31-51 of the *Lrrk2* gene and a mutant exon 31, carrying the R1441G missense mutation, inserted immediately downstream of the second *loxP* site. Homozygous mice are viable and fertile with no overt phenotype. Prior to Cre-mediated recombination, homozygous LRRK2 flox-R1441G mice demonstrate LRRK2 protein levels in brain tissue similar to wildtype controls. After Cre-mediated recombination, the wildtype exons 31-51 will be excised and the mutant exon 31 with the R1441G mutation is expressed in *cre*-expressing tissues. These mice may be useful for studying hereditary Parkinson's disease.
Tags
  • Mouse
Aligning Science Across Parkinson's
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.